Protagenic Therapeutics, Inc.
PTIX
$0.92
-$0.11-10.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 566.00K | 1.51M | 2.21M | 2.72M | 4.10M |
| Total Receivables | -- | -- | 41.50K | 44.00K | 98.60K |
| Inventory | -- | -- | 1.10K | 1.10K | 1.10K |
| Prepaid Expenses | 143.90K | 33.40K | 43.80K | 90.60K | 135.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 709.90K | 1.54M | 2.30M | 2.86M | 4.33M |
|
|
|||||
| Total Current Assets | 709.90K | 1.54M | 2.30M | 2.86M | 4.33M |
| Net Property, Plant & Equipment | 6.20K | 14.60K | 38.80K | 51.40K | 64.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.08M | 2.09M | 2.09M | 2.09M | 2.09M |
| Total Assets | 2.80M | 3.65M | 4.43M | 5.00M | 6.49M |
|
|
|||||
| Total Accounts Payable | 999.70K | 949.50K | 2.03M | 1.64M | 2.08M |
| Total Accrued Expenses | 72.90K | 82.00K | 252.90K | 408.00K | 505.80K |
| Short-term Debt | -- | -- | 4.00M | 4.00M | 4.01M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 544.40K | 3.66M | 3.86M |
| Total Other Current Liabilities | -- | -- | 544.40K | 3.66M | 3.86M |
| Total Current Liabilities | 1.07M | 1.03M | 6.82M | 9.70M | 10.46M |
|
|
|||||
| Total Current Liabilities | 1.07M | 1.03M | 6.82M | 9.70M | 10.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 4.00M | 4.00M | 4.01M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.07M | 1.03M | 6.82M | 9.70M | 10.46M |
|
|
|||||
| Common Stock & APIC | 7.06M | 6.99M | 6.94M | 6.85M | 6.74M |
| Retained Earnings | -4.99M | -4.03M | -9.11M | -11.32M | -10.46M |
| Treasury Stock & Other | -342.00K | -343.10K | -220.00K | -221.20K | -258.20K |
| Total Common Equity | 1.72M | 2.62M | -2.39M | -4.70M | -3.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 1.72M | 2.62M | -2.39M | -4.70M | -3.97M |
| Total Preferred Equity | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.72M | 2.62M | -2.39M | -4.70M | -3.97M |
|
|
|||||